rs397517643
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001267550.2(TTN):c.59205delG(p.Glu19735AspfsTer24) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,386 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001267550.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.59205delG | p.Glu19735AspfsTer24 | frameshift_variant | Exon 300 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.59205delG | p.Glu19735AspfsTer24 | frameshift_variant | Exon 300 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461386Hom.: 0 Cov.: 35 AF XY: 0.00000138 AC XY: 1AN XY: 726988
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2J Pathogenic:1
The heterozygous p.Glu19735AspfsTer24 variant in TTN was identified by our study in the compound heterozygous state, with a VUS, in one individual with limb-girdle muscular dystrophy (LGMD). This variant was absent from large population studies. This nonsense variant leads to a premature termination codon at position 19735, which is predicted to lead to a truncated or absent protein. Loss of function of the TTN gene is an established disease mechanism in autosomal recessive LGMD. In summary, although additional studies are required to fully establish its clinical significance, the p.Glu19735AspfsTer24 variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PVS1 (Richards 2015). -
TTN-related disorder Pathogenic:1
The TTN c.59205delG variant is predicted to result in a frameshift and premature protein termination (p.Glu19735Aspfs*24). This variant has been reported in an individual with left ventricular noncompaction (Supplemental Table 2, Mazzarotto et al. 2021. PubMed ID: 33500567). This variant has also been reported in an individual from a population cohort included in a study designed to retrospectively study TTN gene-disease associations to atrial fibrillation and cardiomyopathy (Table S1, Schiabor Barrett et al. 2023. PubMed ID: 36637017). Additionally, this variant is located in the A-band of the TTN gene, where the majority of truncating variants have been associated with dilated cardiomyopathy (Roberts et al. 2015. PubMed ID:25589632). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic. -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Pathogenic:1
This sequence change creates a premature translational stop signal (p.Glu19735Aspfs*24) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with left ventricular noncompaction (PMID: 33500567). This variant is also known as c.51501delG (p.Glu17167fs). ClinVar contains an entry for this variant (Variation ID: 47147). This variant is located in the A band of TTN (PMID: 25589632). Truncating variants in this region are significantly overrepresented in patients affected with dilated cardiomyopathy (PMID: 25589632). Truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Reported in an individual with left ventricular noncompaction (PMID: 33500567); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23975875, 33500567, 22335739) -
Primary dilated cardiomyopathy Pathogenic:1
The Glu17167fs variant in TTN has not been reported in the literature nor previo usly identified by our laboratory. This frameshift variant is predicted to alter the protein?s amino acid sequence beginning at position 17167 and lead to a pre mature termination codon 24 amino acids downstream. This alteration is then pred icted to lead to a truncated or absent protein. Heterozygous loss of function of the TTN gene is strongly associated with DCM (Herman 2012). In summary, this va riant is likely to be pathogenic, though additional daa is needed to establish t his with certainty. -
Cardiovascular phenotype Pathogenic:1
The c.32010delG variant, located in coding exon 127 of the TTN gene, results from a deletion of one nucleotide at nucleotide position 32010, causing a translational frameshift with a predicted alternate stop codon (p.E10670Dfs*24). This exon is located in the A-band region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). While truncating variants in TTN are present in 1-3% of the general population, truncating variants in the A-band are the most common cause of dilated cardiomyopathy (DCM) (Herman DS et al. N. Engl. J. Med. 2012 Feb;366:619-28; Roberts AM et al. Sci Transl Med. 2015 Jan;7:270ra6). TTN truncating variants encoded in constitutive exons (PSI >90%) have been found to be significantly associated with DCM regardless of their position in titin (Schafer S et al. Nat. Genet. 2017 Jan;49:46-53). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at